nach oben

Journal of Inherited Metabolic Disease

Erschienen in:

01.04.2011 | Mitochondrial Medicine

Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency

verfasst von: Saskia Koene, Peter H. G. M. Willems, Peggy Roestenberg, Werner J. H. Koopman, Jan A. M. Smeitink

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Mitochondrial diseases are a group of heterogeneous pathologies with decreased cellular energy production as a common denominator. Defects in the oxidative phosphorylation (OXPHOS) system, the most frequent one in humans being isolated complex I deficiency (OMIM 252010), underlie this disturbed-energy generation. As biogenesis of OXPHOS complexes is under dual genetic control, with complex II being the sole exception, mutations in both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) are found. Increasing knowledge is becoming available with respect to the pathophysiology and cellular consequences of OXPHOS dysfunction. This aids the rational design of new treatment strategies. Recently, the first successful treatment trials were carried out in patient-derived cell lines. In these studies chemical compounds were used that target cellular aberrations induced by complex I dysfunction. Before the field of human clinical trials is entered, it is necessary to study the effects of these compounds with respect to toxicity, pharmacokinetics and therapeutic potential in suitable animal models. Here, we discuss two recent mouse models for nDNA-encoded complex I deficiency and their tissue-specific knock-outs.

Anderson SL, Chung WK, Frezzo J (2008) A novel mutation in NDUFS4 causes Leigh syndrome in an Ashkenazi Jewish family. J Inherit Metab Dis. doi:10.1007/s10545-008-1049-9

Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120:483–495PubMedCrossRef

Benit P, Steffann J, Lebon S et al (2003) Genotyping microsatellite DNA markers at putative disease loci in inbred/multiplex families with respiratory chain complex I deficiency allows rapid identification of a novel nonsense mutation (IVS1nt -1) in the NDUFS4 gene in Leigh syndrome. Hum Genet 112:563–566PubMed

Benit P, Goncalves S, Dassa EP et al (2008) The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLoS ONE 3:e3208PubMedCrossRef

Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517–529PubMedCrossRef

Betts J, Lightowlers RN, Turnbull DM (2004) Neuropathological aspects of mitochondrial DNA disease. Neurochem Res 29:505–511PubMedCrossRef

Brandt U (2006) Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem 75:69–92PubMedCrossRef

Brini M, Pinton P, King MP et al (1999) A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat Med 5:951–954PubMedCrossRef

Brown MD, Starikovskaya E, Derbeneva O et al (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110:130–138PubMedCrossRef

Budde SM, van den Heuvel LP, Smeitink JA (2002) The human complex I NDUFS4 subunit: from gene structure to function and pathology. Mitochondrion 1–2:109–115CrossRef

Budde SM, van den Heuvel LP, Smeets RJ et al (2003) Clinical heterogeneity in patients with mutations in the NDUFS4 gene of mitochondrial complex I. J Inherit Metab Dis 26:813–815PubMedCrossRef

Caboni P, Sherer TB, Zhang N (2004) Rotenone, deguelin, their metabolites, and the rat model of Parkinson’s disease. Chem Res Toxicol 17:1540–1548PubMedCrossRef

Cande C, Vahsen N, Kouranti I et al (2004) AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 23:1514–1521PubMedCrossRef

Carroll J, Shannon RJ, Fearnley IM et al (2002) Definition of the nuclear encoded protein composition of bovine heart mitochondrial complex I. Identification of two new subunits. J Biol Chem 277:50311–50317PubMedCrossRef

Cheung EC, Joza N, Steenaart NA et al (2006) Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J 25:4061–4073PubMedCrossRef

Choi WS, Kruse SE, Palmiter RD et al (2008) Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci U S A 105:15136–15141PubMedCrossRef

Ciafaloni E, Santorelli FM, Shanske S et al (1993) Maternally inherited Leigh syndrome. J Pediatr 122:419–422PubMedCrossRef

Debray FG, Lambert M, Chevalier I et al (2007) Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 119:722–733PubMedCrossRef

DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348:2656–2668PubMedCrossRef

Distelmaier F, Koopman WJ, van den Heuvel LP (2009a) Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 132(Pt 4):833–842PubMed

Distelmaier F, Visch HJ, Smeitink JA (2009b) The antioxidant Trolox restores mitochondrial membrane potential and Ca2+ -stimulated ATP production in human complex I deficiency. J Mol Med 87:515–522PubMedCrossRef

van Empel V, Bertrand AT, Van der NR (2005) Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 496:e92–e101CrossRef

van Empel V, Bertrand AT, van Oort RJ (2006) EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol 48:824–832PubMedCrossRef

Fernandez-Moreira D, Ugalde C, Smeets R (2007) Arenas J. X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol 61:73–83PubMedCrossRef

Gattermann N, Dadak M, Hofhaus G (2004) Severe impairment of nucleotide synthesis through inhibition of mitochondrial respiration. Nucleosides Nucleotides Nucleic Acids 23:1275–1279PubMedCrossRef

El Ghouzzi V, Csaba Z, Olivier P (2007) Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology. J Neuropathol Exp Neurol 66:838–847PubMedCrossRef

van den Heuvel L, Ruitenbeek W, Smeets R et al (1998) Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 62:262–268PubMedCrossRef

Hirst J, Carroll J, Fearnley IM (2003) The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta 1604:135–150PubMedCrossRef

Hoefs SJ, Dieteren CE, Distelmaier F (2008) NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306–1315PubMedCrossRef

Iuso A, Scacco S, Piccoli C (2006) Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J Biol Chem 281:10374–10380PubMedCrossRef

Janssen R, Smeitink J, Smeets R (2002) CIA30 complex I assembly factor: a candidate for human complex I deficiency? Hum Genet 110:264–270PubMedCrossRef

Janssen RJ, van den Heuvel LP, Smeitink JA (2004) Genetic defects in the oxidative phosphorylation (OXPHOS) system. Expert Rev Mol Diagn 4:143–156PubMedCrossRef

Janssen RJ, Nijtmans LG, van den Heuvel LP (2006) Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 29:499–515PubMedCrossRef

Joza N, Oudit GY, Brown D et al (2005) Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 25:10261–10272PubMedCrossRef

Klein JA, Longo-Guess CM, Rossmann MP et al (2002) The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419:367–374PubMedCrossRef

Koene S, Smeitink J (2009) Mitochondrial medicine: entering the era of treatment. J Intern Med 265:193–209PubMedCrossRef

Koopman WJ, Verkaart S, Visch HJ et al (2005a) Inhibition of complex I of the electron transport chain causes O2−. -mediated mitochondrial outgrowth. Am J Physiol Cell Physiol 288:C1440–C1450PubMedCrossRef

Koopman WJ, Visch HJ, Verkaart S et al (2005b) Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol Cell Physiol 289:C881–C890PubMedCrossRef

Koopman WJ, Visch HJ, Smeitink JA et al (2006) Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytometry A 69:1–12PubMed

Koopman WJ, Hink MA, Verkaart S et al (2007a) Partial complex I inhibition decreases mitochondrial motility and increases matrix protein diffusion as revealed by fluorescence correlation spectroscopy. Biochim Biophys Acta 1767:940–947PubMedCrossRef

Koopman WJ, Verkaart S, Visch HJ (2007b) Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? Am J Physiol Cell Physiol 293:C22–C29PubMedCrossRef

Koopman WJ, Distelmaier F, Hink MA et al (2008a) Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria. Am J Physiol Cell Physiol 294:C1124–C1132PubMedCrossRef

Koopman WJ, Verkaart S, van Emst-de Vries SE et al (2008b) Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment. Biochim Biophys Acta 1777:853–859PubMedCrossRef

Kruse SE, Watt WC, Marcinek DJ et al (2008) Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab 7:312–320PubMedCrossRef

Larsson NG, Rustin P (2001) Animal models for respiratory chain disease. Trends Mol Med 7:578–581PubMedCrossRef

Lash LH (2006) Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem Biol Interact 163:54–67PubMedCrossRef

Lazarou M, McKenzie M, Ohtake A (2007) Analysis of the assembly profiles for mitochondrial- and nuclear-DNA-encoded subunits into complex I. Mol Cell Biol 27:4228–4237PubMedCrossRef

Lazarou M, Thorburn DR, Ryan MT et al (2009) Assembly of mitochondrial complex I and defects in disease. Biochim Biophys Acta 1793:78–88PubMedCrossRef

Leshinsky-Silver E, Lebre AS, Minai L (2009) NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Mol Genet Metab 3:185–189CrossRef

Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216–221PubMedCrossRef

Leonard JV, Schapira AH (2000) Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355:299–304PubMedCrossRef

Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ et al (2000) Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15:123–134PubMedCrossRef

Melov S, Doctrow SR, Schneider JA et al (2001) Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci 21:8348–8353PubMed

Milne JC, Denu JM (2008) The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12:11–17PubMedCrossRef

Morgan-Hughes JA, Darveniza P, Landon DN et al (1979) A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity. J Neurol Sci 43:27–46PubMedCrossRef

Mortiboys H, Thomas KJ, Koopman WJ et al (2009) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurology 64:555–565CrossRef

Murphy MP (2008) Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 1777:1028–1031PubMedCrossRef

Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13PubMedCrossRef

Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 56:629–656CrossRef

Nguyen MH, Jafri MS (2005) Mitochondrial calcium signaling and energy metabolism. Ann N Y Acad Sci 1047:127–137PubMedCrossRef

Nicholls DG (2005) Mitochondria and calcium signaling. Cell Calcium 38:311–317PubMedCrossRef

Palmieri L, Runswick MJ, Fiermonte G (2000) Yeast mitochondrial carriers: bacterial expression, biochemical identification and metabolic significance. J Bioenerg Biomembr 32:67–77PubMedCrossRef

Papa S, Scacco S, Sardanelli AM (2001) Mutation in the NDUFS4 gene of complex I abolishes cAMP-dependent activation of the complex in a child with fatal neurological syndrome. FEBS Lett 489:259–262PubMedCrossRef

Petruzzella V, Papa S (2002) Mutations in human nuclear genes encoding for subunits of mitochondrial respiratory complex I: the NDUFS4 gene. Gene 286:149–154PubMedCrossRef

Petruzzella V, Panelli D, Torraco A, Petruzzella V, Panelli D, Torraco A (2005) Mutations in the NDUFS4 gene of mitochondrial complex I alter stability of the splice variants. FEBS Lett 579:3770–3776PubMedCrossRef

Pospisilik JA, Knauf C, Joza N et al (2007) Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131:476–491PubMedCrossRef

Qi X, Lewin AS, Hauswirth WW et al (2003) Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci 44:1088–1096PubMedCrossRef

Qi X, Sun L, Hauswirth WW et al (2007) Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Arch Ophthalmol 125:268–272PubMedCrossRef

Rahman S, Blok RB, Dahl HH et al (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343–351PubMedCrossRef

Saada A, Vogel RO, Hoefs SJ (2009) Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am J Hum Genet 6:718–727CrossRef

Santorelli FM, Tanji K, Kulikova R et al (1997) Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 238:326–328PubMedCrossRef

Scacco S, Vergari R, Scarpulla RC et al (2000) cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures. J Biol Chem 275:17578–17582PubMedCrossRef

Schapira AH, Cock HR (1999) Mitochondrial myopathies and encephalomyopathies. Eur J Clin Invest 29:886–898PubMedCrossRef

Schon EA, Manfredi G (2003) Neuronal degeneration and mitochondrial dysfunction. J Clin Invest 111:303–312PubMed

Smeitink J, van den Heuvel L, DiMauro S (2001) The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342–352PubMedCrossRef

Smeitink JA, Zeviani M, Turnbull DM et al (2006) Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 3:9–13PubMedCrossRef

Susin SA, Lorenzo HK, Zamzami N et al (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397(6718):441–446

Szabò I, Bock J, Jekle A, Soddemann M (2005) A novel potassium channel in lymphocyte mitochondria. J Biol Chem 280:12790–12798PubMedCrossRef

Szeto HH (2006) Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 8:E521–E531PubMedCrossRef

Tavi P, Hansson A, Zhang SJ et al (2005) Abnormal Ca(2+) release and catecholamine-induced arrhythmias in mitochondrial cardiomyopathy. Hum Mol Genet 14:1069–1076PubMedCrossRef

Ugalde C, Janssen RJ, van den Heuvel LP et al (2004) Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. Hum Mol Genet 13:659–667PubMedCrossRef

Vahsen N, Cande C, Briere JJ et al (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J 23:4679–4689PubMedCrossRef

Valsecchi F, Esseling JJ, Koopman WJ (2009) Calcium and ATP handling in human NADH:ubiquinone oxidoreductase deficiency. Biochim Biophys Acta 10 ePub

Verkaart S, Koopman WJ, Cheek J et al (2007a) Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. Biochim Biophys Acta 1772:1041–1051PubMed

Verkaart S, Koopman WJ, van Emst-de Vries SE (2007b) Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim Biophys Acta 1772:373–381PubMed

Visch HJ, Rutter GA, Koopman WJ et al (2004) Inhibition of mitochondrial Na+-Ca2+ exchange restores agonist-induced ATP production and Ca2+ handling in human complex I deficiency. J Biol Chem 279:40328–40336PubMedCrossRef

Visch HJ, Koopman WJ, Leusink A et al (2006a) Decreased agonist-stimulated mitochondrial ATP production caused by a pathological reduction in endoplasmic reticulum calcium content in human complex I deficiency. Biochim Biophys Acta 1762:115–123PubMed

Visch HJ, Koopman WJ, Zeegers D (2006b) Ca2+-mobilizing agonists increase mitochondrial ATP production to accelerate cytosolic Ca2+ removal: aberrations in human complex I deficiency. Am J Physiol Cell Physiol 291:C308–C316PubMedCrossRef

Vogel R, Nijtmans L, Ugalde C et al (2004) Complex I assembly: a puzzling problem. Curr Opin Neurol 17:179–186PubMedCrossRef

Willems PH, Valsecchi F, Distelmaier F et al (2008) Mitochondrial Ca2+ homeostasis in human NADH:ubiquinone oxidoreductase deficiency. Cell Calcium 44:123–133PubMedCrossRef

Whishaw IQ, Kolb B (1983) Motor systems and regulatory systems In: Whishaw IQ, Kolb B (eds) The behavior of the laboratory rat. Oxford University Press, pp 121–245

Wispe JR, Warner BB, Clark JC et al (1992) Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 25267:23937–23941

Zeviani M, Spinazzola A, Carelli V (2003) Nuclear genes in mitochondrial disorders. Curr Opin Genet 13:262–270CrossRef

Zickermann V, Kerscher S, Zwicker K (2009) Architecture of complex I and its implications for electron transfer and proton pumping. Biochim Biophys Acta 6:574–583

Titel: Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency
verfasst von: Saskia Koene
Peter H. G. M. Willems
Peggy Roestenberg
Werner J. H. Koopman
Jan A. M. Smeitink
Publikationsdatum: 01.04.2011
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 2/2011
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-009-9005-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?

Voice disorders in children with classic galactosemia

Erratum to: Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?

FSH isoform pattern in classic galactosemia

Analysis of synaptic proteins in the cerebrospinal fluid as a new tool in the study of inborn errors of neurotransmission

Biochemical diagnosis of mitochondrial disorders

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin